Lunchtime ASX small cap wrap: who’s landing punches today

Link copied to
clipboard

Here are the key ASX small cap winners and losers at lunch Thursday Nov 15:

The ASX Small Ords was up 0.4 per cent or 9.6 points to 2,598.3 at 12.15pm AEST.

GOING UP

Zinc explorer Peel Mining (ASX:PEX) rocketed more than 40 per cent today after a discovery that included a zinc grading of 40 per cent.

Anything over 12 per cent zinc is considered high grade.

The find came from drilling results at Peel’s “Southern Nights” site in NSW.

The shares jumped from 31c to an intraday high of 44c just after market open.

iSentia Group (ASX:ISD) rose 35 per cent to 29c this morning as the chairman and CEO’s addresses to the company’s annual general meeting were released publicly.

“I want to assure you that we have all been disappointed in Isentia’s recent share price performance. And the Board and executive team are working hard to restore shareholder value,” the company said.

The media monitoring business got walloped in August after a dividend cut, poor results and subdued outlook.

Eden Innovations (ASX:EDE) shares rose 23 per cent to 8.7c after the company told investors its concrete was being used in an American highway repair project.

It involves the reconstruction of 10 miles of the I-70 Interstate Highway, including sinking part of the highway and the establishment of a park above it, using the company’s proprietary EdenCrete.

• Subscribe to our daily newsletter
• Bookmark this link forsmall cap news
• Join our small cap Facebook group
• Follow us on Facebook or Twitter

Shares in Pharmaxis (ASX:PXS) bounced 8pc to an intraday high of 28c after the company revealed that the second of its fatty liver inhibitor drugs had passed safety clinical trials.

Pharmaxis chief Gary Phillips said some big names in pharmaceutical land were lining up to get a piece of the action.

“Several large pharma companies are interested in the Pharmaxis program where both of our LOXL2 inhibitors have now successfully completed phase 1 studies and demonstrated a best in class profile with 24‐hour inhibition of the target enzyme from a single daily dose,” he said.

Here are the best performing ASX small cap stocks at 12.15pm Thursday November 15: 

Swipe or scroll to reveal the full table. Click headings to sort

GOING DOWN

Healthcare wrecks Phosphagenics (ASX:POH) and Factor Therapeutics (ASX:FTT) were among the biggest decliners, though neither has much left to lose.

Both companies opened this morning at 0.3c — but in early traded both dropped a third to 0.2c.

The two stocks lost almost all their value this week, Phosphagenics thanks to a court case loss and Factor after a failed clinical trial.

Here are the worst performing ASX small cap stocks at 12.15pm Thursday November 15:

Swipe or scroll to reveal the full table. Click headings to sort

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

This field is hidden when viewing the form

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Comments

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

IPO Watch

IPO Watch: $6m Mount Hope float puts focus back on copper-rich Cobar Basin

November 11, 2024 | Cameron Drummond and Josh Chiat

News

Closing Bell: Investors left high and dry after China disappoints; Iron ore, oil stocks swing to losses

October 8, 2024 | Eddy Sunarto

News

ASX Small Caps Lunch Wrap: Traders eye China’s “bazooka” as Antilles Gold shines

October 8, 2024 | Eddy Sunarto